Polycystic Ovaries Research Today is a free monthly online journal that collates and summarizes the latest research about Polycystic Ovaries, including details on treatment, symptoms, polycystic ovary syndrome, infertility.

Volume 2 (2005), Issue 1 (January)

1. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
   Clin Endocrinol (Oxf), 62(1): 37-43. [Abstract] [Full-text]
2. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
   J Endocrinol, 184(1): 233-9. [Abstract] [Full-text]
3. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
   J Clin Endocrinol Metab, 90(1): 66-71. [Abstract] [Full-text]
4. beta-Cell function: a key pathological determinant in polycystic ovary syndrome.
   J Clin Endocrinol Metab, 90(1): 310-5. [Abstract] [Full-text]
5. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance.
   J Clin Endocrinol Metab, 90(1): 60-5. [Abstract] [Full-text]
6. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
   J Clin Endocrinol Metab, 90(1): 39-43. [Abstract] [Full-text]
7. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome.
   J Clin Endocrinol Metab, 90(1): 2-5. [Abstract] [Full-text]
8. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
   Eur J Obstet Gynecol Reprod Biol, 118(2): 219-24. [Abstract] [Full-text]
9. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
   Eur J Obstet Gynecol Reprod Biol, 118(2): 209-13. [Abstract] [Full-text]
10. Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test.
    Fertil Steril, 83(1): 232-4. [Abstract] [Full-text]
11. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
    Fertil Steril, 83(1): 130-6. [Abstract] [Full-text]
12. Transabdominal pulse inversion harmonic imaging improves assessment of ovarian morphology in virgin patients with PCOS: comparison with conventional B-mode sonography.
    Eur J Radiol, 53(2): 280-6. [Abstract] [Full-text]
13. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries.
    Hum Reprod, 20(2): 373-81. [Abstract] [Full-text]
14. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience.
    Hum Reprod, 20(2): 420-4. [Abstract] [Full-text]
15. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
    Clin Endocrinol (Oxf), 62(2): 126-31. [Abstract] [Full-text]
16. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.
    Mol Endocrinol, 19(2): 379-90. [Abstract] [Full-text]
17. Health-related quality of life issues in women with polycystic ovary syndrome.
    J Obstet Gynecol Neonatal Nurs, 34(1): 12-20. [Abstract] [Full-text]
18. Cardiovascular risk in women with polycystic ovarian syndrome (PCOS).
    J Clin Pathol, 58(2): 151-4. [Abstract] [Full-text]
19. Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome.
    Clin Chem, 51(2): 416-23. [Abstract] [Full-text]

© 2004-2008 Polycystic Ovaries Research Today. All Rights Reserved.